• Tidak ada hasil yang ditemukan

Chantigy Jacinda - SGU Repository

N/A
N/A
Nguyễn Gia Hào

Academic year: 2023

Membagikan "Chantigy Jacinda - SGU Repository"

Copied!
3
0
0

Teks penuh

(1)

FINANCIAL PERFORMANCE ANALYSIS OF PHARMACEUTICAL COMPANIES LISTED ON THE INDONESIA STOCK EXCHANGE (IDX) BEFORE AND AFTER THE NATIONAL HEALTHCARE INSURANCE COVERAGE

(JKN – JAMINAN KESEHATAN NASIONAL) PROGRAM BY BPJS KESEHATAN Page 72 of 76

Chantigy Jacinda REFERENCES

References

Bhunia, A. (2011). Financial Performance Analysis-A Case Study. Current Research Journal of Social Sciences 3 (3): 269-275, 1.

Branco, M. C., & Rodrigues, L. L. (2006). Corporate Social Responsibility and Resource-Based Perspectives. Journal of Business Ethics 69:111-132, 11-13.

Chapela, V. A., Premje, N., & Stevenson, B. (2015). Industry Explorations: Indonesia Pharmaceuticals 2015. Global Business Reports.

Chapela, V. A., Premjee, N., & Stevenson, B. (2016). Indonesia Pharmaceuticals 2015.

Global Business Report.

Chua, K.-P., & Casoy, F. (2008). The Case for Universal Health Care. Reston: AMSA Jack Rutledge Fellow.

Cooper, D. R., & Schindler, P. S. (2014). Business Research Methods, Twelfth Edition.

New York: McGraw-Hill Education (Asia).

Danzon, P. A., & Pauly, M. V. (2002). Health Insurance and the Growth in Pharamceutical Expenditures. Journal of Law and Economics, vol. XLV, 587-613.

FDA. (2016, 4 14). Retrieved from FDA - U.S. Food and Drug Administration:

http://www.fda.gov/Drugs/ResourcesForYou/Consumers/BuyingUsingMedicineSafel y/UnderstandingGenericDrugs/

Hartmann, M. (2011). Corporate Social Responsibility in the Food Sector. European Review of Agricultural Economics Vol. 38 (3) pp. 297-324, 19.

Indonesia, P. R. (2011). Republic of Indonesia's Law (UU) Number 24 Year 2011.

Jakarta.

Kesehatan, B. (2014). Info BPJS Kesehatan. KIS Tidak Tumpang Tindih dengan Kartu BPJS Kesehatan.

(2)

FINANCIAL PERFORMANCE ANALYSIS OF PHARMACEUTICAL COMPANIES LISTED ON THE INDONESIA STOCK EXCHANGE (IDX) BEFORE AND AFTER THE NATIONAL HEALTHCARE INSURANCE COVERAGE

(JKN – JAMINAN KESEHATAN NASIONAL) PROGRAM BY BPJS KESEHATAN Page 73 of 76

Chantigy Jacinda Kurniawan, H., Nuky, E., & Andriyanto, H. (2016). Profit Margin Obat hingga 800%, Gratifikasi ke Dokter Marak. International Pharmaceutical Manufaturers Group.

Mantyo, J. (2014). Pengertian Obat Generik (Bermerk, Berlogo) dan Obat Paten.

Retrieved from Obat Apa Saja: http://www.obatapasaja.com/2015/04/pengertian-obat- generik-bermerekberlogo.html

Ministry, I. H. (2013). Indonesia Patent No. Number 328/MENKES/SK/VIII/2013.

Ministry, I. H. (2014). Buku Pegangan Sosialisasi Jaminan Kesehatan Nasional (JKN) dalam Sistem Jaminan Sosial Nasional. Jakarta: Pusat Promosi Kesehatan Kementerian Kesehatan RI.

My Accounting Course. (n.d.). Retrieved from

http://www.myaccountingcourse.com/financial-ratios/return-on-equity.

Parab, S. (2014). Impact of the Affordable Care Act on Pharmaceutical and Biotech Industry. Cary, New Castle: Oakham Development Gourp Inc.

Research, B. (2016). Indonesia Pharmaceuticals & Healthcare Report Q2 2016.

Business Monitor International Ltd.

Roslina, d., Jani, d., & Puji, d. L. (2016, May). Interview with Doctors. (C. Jacinda, Interviewer)

S, S. (2015, February 4). Difference Between Net Sales and Net Income. Retrieved from Key Differences: http://keydifferences.com/difference-between-net-sales-and-net- income.html

Sanzo, K. M. (2010). Healthcare Reform Law: Impact on Pharmaceutical Manufacturers. Washington: Morgan Lewis - Washington Government Relations and Public Lawflash.

Sentot, Joko, Nono, & Hoi, P. (2016, May). Interview with Pharmaceutical Company's Workers. (C. Jacinda, Interviewer)

Tanner, A. E., Ranti, L., & Lolo, W. A. (2015). Evaluasi Pelaksanaan Pelayanan Resep Obat Generik pada Pasien BPJS Rawat jalan di RSUP. Prof. DR. R.D. Kandou Manado Periode januari-Juni 2014. Jurnal Ilimah Farmasi - UNSRAT Vol. 4 No. 4 November 2015 ISSN 2302-2493, 58.

(3)

FINANCIAL PERFORMANCE ANALYSIS OF PHARMACEUTICAL COMPANIES LISTED ON THE INDONESIA STOCK EXCHANGE (IDX) BEFORE AND AFTER THE NATIONAL HEALTHCARE INSURANCE COVERAGE

(JKN – JAMINAN KESEHATAN NASIONAL) PROGRAM BY BPJS KESEHATAN Page 74 of 76

Chantigy Jacinda Teh, I., Toh, S., & Chan, M. (2015). Universal Health Coverage in Indonesia (one year on). Singapore: The Economist - Intelligence Unit.

Tools, A. (2016). Retrieved from http://www.accountingtools.com/definition-net-sales.

Tutor, M. S. (2010). Performing Normality in SPSS. Retrieved from http://www.maths- statistics-tutor.com/normality_test_pasw_spss.php

University, K. S. (n.d.). University Libraries. Retrieved from Kent University Library:

http://libguides.library.kent.edu/SPSS/PairedSamplestTest

Videau, J.-Y. (2000). Generic drugs: the hidden issues of quality and cost. WHO Drug Information, p. 77. Retrieved from World Health Organization International - Medicine Docs: http://apps.who.int/medicinedocs/en/d/Jh1463e/2.html

Wathen, J. (2015). 5 Ways to Improve Return on Equity. TMF Value Magnet.

Wikipedia. (n.d.). Retrieved from https://id.wikipedia.org/wiki/BPJS_Kesehatan

Wikipedia. (2014). BPJS Kesehatan. Retrieved from

https://id.wikipedia.org/wiki/BPJS_Kesehatan

Referensi

Dokumen terkait

This can happen because the IPO decision is a complex decision, therefore it will lead to new losses and costs Dintha & Supriatna, 2019 Of the 12 companies whose RORA data